Posted on
Jul 3, 2026
AI Medical Coder: Automating Level 4 & 5 Capture for Maximum Reimbursement
Clinical Update — June 2026: This Operations Playbook has been revised to reflect the AMA's May 2026 CPT Appendix S taxonomy update for AI-assisted clinical services, CMS CY2026 Physician Fee Schedule final rule adjustments to E/M documentation thresholds, and updated FHIR R4 Provenance binding specifications. All MDM scoring references align with the current AMA E/M office visit guidelines effective January 1, 2023, as clarified through the 2026 CPT errata cycle. ICD-10-CM code references reflect FY2026 addenda.
AI Medical Coder: Automating Level 4 & Level 5 E/M Capture With Real-Time MDM Auditing
TL;DR — Why Primary Care Medical Directors Should Read This
Roughly 30% of office visits are under-coded because physicians avoid documenting the "Complexity of Data Reviewed" element in Medical Decision Making. AMA 2023+ E/M rules demand granular, auditable proof—counting unique tests, identifying external notes by distinct source, and explicitly documenting independent interpretation and specialist discussions. Scribing.io's real-time MDM Ledger automates this granularity: de-duplicating labs, normalizing external sources by NPI, diarizing phone consults, and binding every data point to FHIR Provenance for a CMS-compliant audit packet. The result is defensible Level 4 (99214) and Level 5 (99215) capture without upcoding risk, closing the revenue gap that under-coding creates across your practice.
The Under-Coding Crisis: Why 30% of Visits Are Billed Below Clinical Work
What the AMA Taxonomy Misses: The Granular MDM Documentation Gap
Scribing.io Clinical Logic: High-Stakes Outpatient MDM in Real Time
The MDM Ledger Architecture: Real-Time Data Deduplication and Source Normalization
Technical Reference: ICD-10 Documentation Standards for Complex Multi-Condition Visits
Level 4 vs. Level 5 E/M: A Granular MDM Scoring Comparison
Audit-Ready by Design: FHIR Provenance and the CMS 6-Year Lookback
Implementation Roadmap for Primary Care Medical Directors
The Under-Coding Crisis: Why 30% of Visits Are Billed Below Clinical Work
Every Primary Care Medical Director has seen it: a physician finishes a 25-minute encounter managing a patient with three chronic conditions, reviews an outside ED note, interprets an ECG, calls a specialist—then bills a 99214 because they cannot articulate why the data complexity justifies a higher level. The note reads "outside notes reviewed, labs reviewed" and the physician moves on, leaving defensible revenue on the table.
This is not a knowledge problem. It is a documentation friction problem. And it is precisely the problem Scribing.io was built to eliminate.
Current clinical benchmarks—consistent with findings reported in JAMA Internal Medicine research on E/M coding accuracy—indicate that approximately 30% of outpatient visits are under-coded because clinicians are reluctant to detail the "Complexity of Data Reviewed" element within Medical Decision Making (MDM). The reluctance is rational: under the AMA's 2023+ E/M framework, "data reviewed" is not a free-text narrative flourish. It requires specific, countable, source-attributed evidence that can survive a payer audit. When the documentation burden of proving what was reviewed exceeds the cognitive bandwidth available between patients, physicians default to the safer, lower-level code.
The downstream financial impact is substantial. For a 10-physician Family Medicine practice averaging 25 patient encounters per physician per day, a systematic 30% under-coding rate on visits that clinically qualify for 99215 translates to a revenue shortfall exceeding $300,000 annually—without any change in clinical work performed. Across a health system with 50 primary care physicians, that number approaches seven figures. These are not hypothetical dollars gained by upcoding. They are real dollars lost by under-documenting work that was already performed.
The pattern extends beyond primary care. We see identical documentation avoidance in Psychiatry, where complex medication management visits with external collateral review routinely bill at 99213 or 99214 despite meeting 99215 data thresholds. The mechanism is the same everywhere: the physician does the work, the note fails to prove it, and the code drops.
The solution is not "code higher." The solution is to make the documentation granularity that justifies the correct code automatic, auditable, and embedded in the clinical workflow so physicians never have to choose between documentation fidelity and patient care velocity. See our real-time MDM Ledger that auto-binds Category 1/2/3 data to FHIR Provenance and one-click exports an auditor-ready packet into Epic/Cerner.
What the AMA Taxonomy Misses: The Granular MDM Documentation Gap
The AMA's CPT Appendix S taxonomy—updated May 2026—provides a useful classification framework for AI in medical services, distinguishing between assistive, augmentative, and autonomous software outputs. It addresses a fundamentally different problem than the one that drives under-coding in primary care.
Appendix S classifies what AI does. It does not address how AI helps physicians prove what they did.
This is the critical gap. The AMA taxonomy asks: "Is this software assistive, augmentative, or autonomous?" The Primary Care Medical Director asks: "Can this software ensure my physicians capture the correct E/M level for the clinical work they already perform—and survive an audit?"
Most published guidance—including the AMA's own E/M documentation resources and CMS's Evaluation and Management resources—treats "data reviewed" as a monolithic concept. A typical instruction reads: "Document the data you reviewed and ordered." But the 2023+ MDM table demands far more specificity.
The Three Granularity Requirements Most Resources Ignore
1. Unique Test Counting, Not Panel Subcomponent Counting
When a physician orders a Comprehensive Metabolic Panel (CMP), that is one test for MDM purposes—not 14 individual results. However, if a separately ordered INR is also reviewed, that is a second unique test. The distinction matters because the threshold between Moderate and High data complexity can hinge on the count of unique tests reviewed or ordered. Most EHR templates fail to enforce this distinction, leading to either under-counting (treating CMP + INR as "labs reviewed") or over-counting (listing every CMP subcomponent as a separate data point, which is indefensible under audit).
2. External Source Identification by Unique Origin
Reviewing "outside records" is not a data point. Reviewing a discharge summary from St. Mary's Hospital Emergency Department (Source 1) and an office note from Dr. Patel's cardiology practice (Source 2) is two external sources. The AMA 2023+ framework requires each external source to be identified distinctly. A PDF scan sitting in an EHR media tab does not automatically constitute "reviewed" data unless the note explicitly references its content and origin. This requirement is detailed in the AMA's E/M descriptors and guidelines.
3. Independent Interpretation and External Physician Discussion
Two of the highest-value MDM data activities—independent interpretation of a test (e.g., a physician personally reading an ECG rather than relying on the machine read) and discussion with an external physician about management—require explicit documentation of the interpretation rendered or the physician contacted, the content discussed, and the time. A note that reads "discussed with cardiology" is insufficient. A note that reads "Discussed warfarin management with Dr. Sarah Chen, cardiology (NPI: 1234567890), at 2:47 PM for 2 minutes; agreed to hold warfarin pending repeat INR Thursday" qualifies for Category 3 credit.
Why Post-Encounter AI Coding Falls Short
Most AI medical coding solutions operate as post-encounter auditors: the physician writes the note, and the software suggests a code afterward. This approach is better than nothing, but it cannot solve the granularity problem because the granular data was never captured in the note in the first place. You cannot extract a Category 3 phone consult detail from a note that says "discussed with cardiology." You cannot count unique external sources from "outside notes reviewed." The data gap exists at the point of documentation, not at the point of code selection.
Scribing.io operates differently—as a real-time MDM Ledger embedded in the encounter workflow.
Scribing.io Clinical Logic: High-Stakes Outpatient MDM for a 67-Year-Old With Type 2 Diabetes and New Atrial Fibrillation
Consider the encounter that epitomizes the under-coding problem:
Patient: A 67-year-old male with type 2 diabetes mellitus (E11.65) and newly diagnosed atrial fibrillation (I48.91) on warfarin presents to an internist's office with palpitations. He was seen in the ED three days ago and had a cardiology consult from an outside practice. The internist reviews the ED records, reviews the cardiology consult, personally interprets an in-office ECG, calls the cardiologist to discuss anticoagulation management, reviews the patient's CMP and a separately ordered INR, and adjusts the warfarin dose with a monitoring plan.
What typically happens: The internist bills 99214 (Level 4, Moderate MDM). The note reads: "Reviewed outside notes and ECG. Labs reviewed. Discussed with cardiology. Warfarin dose adjusted." The physician knows this was a complex visit but documents conservatively because "outside notes and ECG reviewed" feels risky to defend at a higher level. The practice loses the 99215–99214 differential—roughly $60–$80 per encounter depending on payer mix—multiplied across every similar visit, every day.
What happens with Scribing.io's live MDM Ledger:
Step-by-Step MDM Ledger Workflow
MDM Data Activity | Without Scribing.io (Typical Documentation) | With Scribing.io MDM Ledger (Automated Granular Capture) | MDM Category Credit |
|---|---|---|---|
External Source #1: ED discharge summary | "Outside notes reviewed" | Auto-linked: St. Mary's Hospital ED, Discharge Summary, Dr. James Torres (NPI: 1928374650), DOS: 06/27/2026, FHIR DocumentReference ID: abc-1234 | Category 1 — Each unique source |
External Source #2: Outside cardiology consult note | (Merged into "outside notes reviewed") | Auto-linked: HeartCare Associates, Consult Note, Dr. Sarah Chen (NPI: 1234567890), DOS: 06/28/2026, FHIR DocumentReference ID: def-5678. Ingested via HL7 v2 MDM/XDS (Media tab PDF not exposed via FHIR R4). | Category 1 — Each unique source |
Independent ECG Interpretation | "ECG reviewed" (ambiguous: machine read or independent?) | Prompted: Physician enters 1-line interpretation → "Atrial fibrillation with controlled ventricular rate of 78 bpm, no acute ST-T wave changes. Independent interpretation by Dr. Miller." Auto-flagged as independent interpretation distinct from machine read. | Category 2 — Independent interpretation |
Phone Consult with Cardiologist | "Discussed with cardiology" | Diarized from clinic audio: Phone consult with Dr. Sarah Chen, Cardiology (NPI: 1234567890), 2:47 PM EDT, duration 2 min 14 sec. Content: Agreed to reduce warfarin to 4 mg daily, recheck INR in 3 days, target INR 2.0–3.0 given new AF diagnosis. | Category 3 — Discussion with external physician |
Lab Review: CMP | "Labs reviewed" | Auto-counted: CMP = 1 unique test (14 subcomponents de-duplicated to 1 per AMA counting rules). | Category 1 — Tests ordered/reviewed |
Lab Review: INR (separately ordered) | (Merged into "labs reviewed") | Auto-counted: INR = 1 additional unique test (separately ordered, not part of CMP panel). Total unique tests: 2. | Category 1 — Tests ordered/reviewed |
Drug Therapy Monitoring | "Warfarin adjusted" | Auto-flagged: Warfarin identified as drug therapy requiring intensive monitoring for toxicity (narrow therapeutic index, INR monitoring). Suggested monitoring plan language: "Warfarin dose reduced to 4 mg daily. INR recheck in 3 days at LabCorp. Patient counseled on signs of bleeding. Follow-up in 1 week or sooner if INR >3.5." | Risk of Complications / Morbidity — Prescription drug management requiring intensive monitoring |
The MDM Level Determination
With these data elements captured and attributed, the MDM Ledger scores the encounter across all three MDM axes:
Number and Complexity of Problems Addressed: Two chronic conditions — type 2 diabetes with hyperglycemia (E11.65) requiring ongoing medication management, and new atrial fibrillation (I48.91) with initiation of anticoagulation. A new problem requiring a prescription drug qualifies as Moderate to High. Combined with the chronic illness requiring drug management = High.
Amount and/or Complexity of Data Reviewed: Two unique external sources (Category 1 × 2) + independent interpretation of ECG (Category 2) + external physician discussion with documented name/NPI/time/content (Category 3) + two unique lab tests reviewed (Category 1). Per the AMA MDM data table, achieving Category 3 credit or the combination of Category 1 + Category 2 qualifies as Extensive data complexity. This encounter achieves both.
Risk of Complications and/or Morbidity or Mortality: Warfarin is a prescription drug requiring intensive monitoring for toxicity (narrow therapeutic index, bleeding risk, INR variability). This alone qualifies as High risk per the CMS/AMA risk table.
Result: Two of three MDM elements meet High complexity. Under the 2023+ E/M rules, where MDM level is determined by the two highest of three elements, this encounter qualifies as 99215 — High MDM.
Without Scribing.io, the same clinical work generates a note that supports only 99214 because the documentation lacks the granularity to prove High data complexity. The physician did the work. The note did not capture it. The code drops.
With Scribing.io, the live MDM Ledger produces a clean 99215 with an auditor-ready packet attached directly into Epic or Cerner—denial risk reduced, revenue per visit aligned to clinical work performed.
The MDM Ledger Architecture: Real-Time Data Deduplication and Source Normalization
The MDM Ledger is not a charting template or a coding suggestion pop-up. It is a parallel data structure that runs alongside the encounter, ingesting structured and unstructured clinical data from multiple channels and normalizing it against AMA E/M counting rules in real time.
Four Core Technical Capabilities
1. Lab De-Duplication Engine
The engine maps incoming lab results to their parent order using LOINC codes and the ordering facility's compendium. A CMP (LOINC panel 24323-8) is recognized as a single orderable test regardless of how many individual analytes the EHR displays. A separately ordered PT/INR (LOINC 6301-6 / 34714-6) is counted as an additional unique test. This prevents both under-counting ("labs reviewed") and over-counting (listing 14 CMP components individually), either of which creates audit vulnerability.
2. External Source Normalization
External documents arrive in EHRs through multiple pathways: Direct messaging, fax-to-EHR conversion, patient portal uploads, and HL7 v2 MDM messages. Many land in the Media tab as unstructured PDFs—not exposed through standard FHIR R4 DocumentReference APIs. Scribing.io addresses this by:
Ingesting HL7 v2 MDM/TXA segments and XDS.b metadata where available
Extracting sending facility OID, provider NPI, and document type from message headers
Creating normalized FHIR DocumentReference resources with unique
authorandcustodianreferencesPresenting each source to the physician as a discrete, attributable data item in the MDM Ledger rather than a generic "outside records" blob
3. Phone Consult Diarization
Ambient audio capture—already active for encounter documentation—extends to phone consultations when the physician initiates a specialist call during the visit. The diarization engine separates speakers, identifies the external physician by matching voice segments against known call context (outbound number, scheduled callback), and extracts:
Specialist name and NPI (cross-referenced against CMS NPPES)
Call start time and duration
Discussion content summarized into a structured Category 3 data element
The physician reviews and confirms the diarized summary before it is committed to the note. This is not autonomous documentation—it is augmentative capture that requires physician attestation, consistent with AMA Appendix S augmentative AI classification.
4. FHIR Provenance Binding
Every data item in the MDM Ledger—each external source, each lab result, each independent interpretation, each phone consult—is linked to a FHIR Provenance resource that records:
agent: The physician who reviewed or interpreted the dataentity: The source document or test result (by FHIR resource ID)recorded: Timestamp of review/interpretationactivity: The type of MDM activity (review, independent interpretation, external discussion)
This creates a tamper-evident, exportable audit chain that persists independently of the narrative note—critical for compliance with CMS's 6-year overpayment lookback window under the 60-day repayment rule.
Technical Reference: ICD-10 Documentation Standards for Complex Multi-Condition Visits
Accurate E/M leveling depends on accurate problem identification, and accurate problem identification depends on ICD-10-CM code specificity. Vague or unspecified codes weaken MDM justification in two ways: they reduce the documented complexity of problems addressed, and they trigger payer edits that slow or deny reimbursement.
For the clinical scenario described above, the relevant codes are:
E11.65 - Type 2 diabetes mellitus with hyperglycemia; I48.91 - Unspecified atrial fibrillation
How Scribing.io Ensures Maximum Code Specificity
E11.65 — Type 2 diabetes mellitus with hyperglycemia: Scribing.io's real-time AI Coder cross-references the problem list, active medications (metformin, insulin), and lab values (glucose, HbA1c) against the ICD-10-CM Official Guidelines for Coding and Reporting. If the physician documents "diabetes" without specifying type, hyperglycemic status, or complications, the system prompts for clarification before note finalization. This prevents the common fallback to E11.9 (Type 2 diabetes mellitus without complications), which understates disease complexity and weakens the "Number and Complexity of Problems" MDM element.
I48.91 — Unspecified atrial fibrillation: While I48.91 is the correct code when AF type (paroxysmal, persistent, permanent) has not yet been determined—as in a new diagnosis—Scribing.io flags this as a specificity opportunity. If the ED note or cardiology consult characterizes the AF as paroxysmal (I48.0), persistent (I48.1), or chronic/permanent (I48.2/I48.21), the system suggests upgrading specificity based on available external documentation. This prevents both under-specification (which invites payer queries) and over-specification (assigning a type not supported by the record).
Multi-Condition Documentation Integrity
For encounters involving multiple chronic conditions, Scribing.io enforces ICD-10-CM Guideline I.B.8 (code to highest specificity) and Guideline IV.J (sequencing for coexistence): the code most relevant to the reason for the visit is listed first, with additional codes reflecting all conditions actively managed. The system also cross-references the CMS ICD-10-CM code edits for mutually exclusive code pairs, manifestation/etiology sequencing requirements, and age/sex conflicts—catching errors that would otherwise trigger claim denials days or weeks after the encounter.
Level 4 vs. Level 5 E/M: A Granular MDM Scoring Comparison
The financial and clinical distinction between 99214 and 99215 is significant but frequently misunderstood. The table below maps the specific MDM thresholds that differentiate these levels, with the clinical scenario data overlaid.
MDM Element | 99214 — Moderate Complexity | 99215 — High Complexity | This Encounter (With Scribing.io) |
|---|---|---|---|
Number & Complexity of Problems | 2+ chronic illnesses with mild exacerbation, or 1 undiagnosed new problem with uncertain prognosis, or 1 acute illness with systemic symptoms | 1+ chronic illness with severe exacerbation or progression, OR 1+ acute/chronic illness posing threat to life or bodily function | High: New AF with anticoagulation initiation (new problem requiring drug with intensive monitoring) + DM with hyperglycemia (chronic illness with active management) |
Amount & Complexity of Data | Moderate: Must meet Category 1 requirements (tests, external records) — limited sources, no independent interpretation or external discussion required | Extensive: Must meet Category 1 requirements PLUS at least one of Category 2 (independent interpretation) OR Category 3 (external physician discussion) | Extensive (High): 2 unique external sources + 2 unique tests (Cat 1) + independent ECG interpretation (Cat 2) + phone consult with cardiologist with NPI/time/content (Cat 3) |
Risk of Complications / Morbidity / Mortality | Moderate: Prescription drug management; decision regarding minor surgery with identified risk factors; diagnosis or treatment significantly limited by social determinants | High: Drug therapy requiring intensive monitoring for toxicity; decision regarding emergency major surgery; decision regarding hospitalization or DNR | High: Warfarin — narrow therapeutic index, requires INR monitoring, bleeding risk, documented monitoring plan |
Resulting E/M Level | 2 of 3 elements at Moderate | 2 of 3 elements at High | 99215: All 3 elements meet High threshold |
2026 National Average Reimbursement (Medicare) | ~$128 | ~$188 | Delta: ~$60 per encounter recovered |
At scale, that $60 per-encounter delta applied to the estimated 30% of under-coded visits across a mid-size primary care group represents the single largest recoverable revenue opportunity that does not require seeing more patients, hiring more staff, or changing clinical protocols.
Audit-Ready by Design: FHIR Provenance and the CMS 6-Year Lookback
Defensible coding is not just about getting the level right at the time of billing. It is about maintaining a retrievable, tamper-evident record that proves the level was justified years after the encounter. CMS's 60-day repayment rule (42 CFR § 401.305) establishes a 6-year lookback window for overpayment identification—meaning a 99215 billed today must be defensible through 2032.
The Narrative Note Problem
Most E/M defense today relies on the narrative clinical note. But narrative notes are fragile audit artifacts:
They can be amended (raising questions about contemporaneous documentation)
They do not inherently prove when data was reviewed (only that the physician wrote "reviewed")
They do not link to the source documents that were purportedly reviewed
They cannot independently verify that a phone consult occurred at the stated time
How the MDM Ledger Solves This
Scribing.io's FHIR Provenance binding creates a parallel evidence chain that supplements the narrative note with structured, timestamped, source-linked metadata:
Audit Question | Narrative Note Answer | FHIR Provenance Answer |
|---|---|---|
Did the physician review the ED discharge summary? | "Outside notes reviewed" (unspecified) | Provenance resource: agent = Dr. Miller, entity = DocumentReference/abc-1234 (St. Mary's ED, Dr. Torres, NPI 1928374650), recorded = 2026-06-30T14:22:00Z |
Was the ECG interpretation independent? | "ECG reviewed" (ambiguous) | Provenance resource: agent = Dr. Miller, activity = "independent-interpretation", entity = DiagnosticReport/ecg-7890, recorded = 2026-06-30T14:31:00Z, note = "AF, controlled rate 78, no ST changes" |
Did the phone consult actually happen? | "Discussed with cardiology" | Provenance resource: agent = Dr. Miller + Dr. Chen (NPI 1234567890), activity = "external-discussion", recorded = 2026-06-30T14:47:00Z, duration = PT2M14S, content summary attested by Dr. Miller |
Was warfarin monitoring plan documented? | "Warfarin adjusted" | Provenance resource: entity = MedicationRequest/warfarin-456, activity = "intensive-monitoring-plan", recorded = 2026-06-30T14:55:00Z, plan = "4mg daily, INR recheck 3d, follow-up 1wk" |
This packet is exportable as a single, structured document via one-click integration into Epic (as a SmartData Element or Note Addendum) or Cerner (as a PowerNote component). The auditor does not need to reconstruct the MDM from a narrative note. They receive a structured, timestamped, source-linked evidence file that maps directly to the AMA MDM table.
Implementation Roadmap for Primary Care Medical Directors
Deploying real-time MDM auditing is a clinical operations initiative, not an IT project. The following roadmap reflects implementation patterns from Scribing.io deployments across primary care, internal medicine, and multi-specialty practices.
Phase 1: Baseline Audit (Weeks 1–2)
Pull a random sample of 200 encounters per physician from the prior 90 days
Compare billed E/M level against documented MDM elements using the AMA 2023+ MDM table
Quantify the under-coding rate: what percentage of encounters documented sufficient clinical complexity for a higher E/M level but were billed lower?
Identify the specific documentation gap: In nearly all cases, it will be "Amount and/or Complexity of Data Reviewed" — the element that requires the granularity described above
Phase 2: MDM Ledger Configuration (Weeks 2–4)
Configure Scribing.io's EHR integration (Epic via FHIR R4 + HL7 v2 ADT/MDM feeds; Cerner via FHIR R4 + Millennium Open APIs)
Map practice-specific lab compendium to LOINC for accurate panel de-duplication
Configure external source ingestion pathways (Direct messaging, fax-to-EHR, patient portal uploads)
Set ambient audio capture parameters for phone consult diarization (microphone placement, consent workflow per state law)
Phase 3: Physician Onboarding (Weeks 3–5)
Train physicians on the MDM Ledger interface: where it surfaces during the encounter, how to confirm/edit auto-captured data elements, how to enter the 1-line independent interpretation prompt
Run 10 encounters per physician in "shadow mode" — MDM Ledger runs and generates the audit packet, but does not alter the submitted code. Compare Ledger-recommended code vs. physician-selected code to quantify the capture gap in real time
Review shadow-mode results with each physician individually. The goal is not to say "you should have coded higher" but to show "here is the data you reviewed that your note did not capture — and here is what the Ledger would have documented for you"
Phase 4: Go-Live and Continuous Monitoring (Week 6+)
Activate real-time MDM Ledger with AI Coder recommendations visible to the physician before note finalization
Physician retains full authority over final code selection — the system recommends, it does not auto-submit
Monitor weekly dashboards: E/M level distribution shift, denial rate for 99215 claims, audit packet generation rate, physician adoption metrics
Conduct monthly compliance reviews: random sample of Ledger-supported 99215 claims reviewed by a certified coder to validate ongoing accuracy
Expected Outcomes (90-Day Benchmark)
Metric | Pre-Implementation Baseline | 90-Day Post-Implementation Target |
|---|---|---|
99215 capture rate (% of total E/M) | 8–12% | 18–25% (aligned to clinical complexity distribution) |
99214 capture rate | 55–65% (inflated by down-coding from 99215) | 45–55% (normalized) |
99215 denial rate | 6–10% (due to insufficient documentation) | <2% (auditor-ready packets reduce payer challenges) |
Average documentation time per encounter | Baseline | Net neutral or reduced (Ledger automates data attribution that physicians previously performed manually or skipped entirely) |
Revenue per encounter (blended) | Baseline | +8–14% increase attributable to corrected E/M distribution |
These are not projections based on upcoding. They reflect the revenue recovery that occurs when documentation accuracy matches clinical work already performed. The NIH and JAMA literature consistently supports the finding that physician documentation under-represents clinical complexity, particularly in data-intensive encounters. Scribing.io does not change the clinical work. It makes the documentation tell the truth about the clinical work.
The core principle is straightforward: doctors under-code 30% of visits because they don't want to document the "Complexity of Data Reviewed." Scribing.io's AI Coder audits the note in real time to ensure the CPT code matches the clinical work performed. That is the entire value proposition—no more, no less.



